Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis
1 other identifier
observational
301
1 country
1
Brief Summary
It appears that the heavyness of flu pathology, the diagnosis limits and the validity of it was well studied in the last years.However, the economical impact and the organisation benefit in emergency service is not yet evaluated Our purpose is to study the impact of implementation of fast flu diagnosis by molecular biology available in emergency service in the economic field .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2016
CompletedFirst Submitted
Initial submission to the registry
September 21, 2017
CompletedFirst Posted
Study publicly available on registry
September 26, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedAugust 9, 2018
August 1, 2018
11 months
September 21, 2017
August 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
time to have the result of the biological test
3 hours
Interventions
Test A i Flu A\&B implemented in emergency service
Eligibility Criteria
each patient admitted in emergy service between february 2016 and april 2016
You may qualify if:
- respiratory symptoms
- fever \>38°C
- general symptoms of flu like pathology
You may not qualify if:
- cognitive disorders
- patient with guardianship
- patient already having a flu diagnosis in the last 7 days
- without social protection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
GANANSIA Olivier, MD
GHPSJ
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2017
First Posted
September 26, 2017
Study Start
January 22, 2016
Primary Completion
December 31, 2016
Study Completion
June 30, 2018
Last Updated
August 9, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share